United Capital Financial Advisers, LLC Embecta Corp. Transaction History

United Capital Financial Advisers, LLC

  • $19.9 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$25.29 - $35.48 $137,678 - $193,153
-5,444 Reduced 33.68%
10,721 $271,000
Q3 2022

Nov 14, 2022
SELL
$24.0 - $33.42 $14,040 - $19,550
-585 Reduced 3.49%
16,165 $465,000
Q2 2022

Aug 11, 2022
BUY
$24.78 - $33.36 $415,065 - $558,780
16,750 New
16,750 $424,000

Others Institutions Holding EMBC

# of Institutions
403
Shares Held
51.2M
Call Options Held
162K
Put Options Held
61K
View Full List

About Embecta Corp.

EMBC Quotes by TradingView
  • Ticker EMBC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 57,836,500
  • Market Cap $846M
  • Description
  • Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...
More about EMBC
Track This Portfolio

Track United Capital Financial Advisers, LLC Portfolio

Follow United Capital Financial Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of United Capital Financial Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on United Capital Financial Advisers, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email